Advisory Services Network, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisory Services Network, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q4 2020$5,000
-28.6%
250
-53.1%
0.00%
Q3 2020$7,000
-53.3%
533
-50.8%
0.00%
-100.0%
Q1 2020$15,000
-48.3%
1,0830.0%0.00%
-50.0%
Q4 2019$29,000
+93.3%
1,083
+104.3%
0.00%
+100.0%
Q3 2019$15,0000.0%5300.0%0.00%0.0%
Q2 2019$15,000
+87.5%
530
+112.0%
0.00%0.0%
Q1 2019$8,000
+14.3%
2500.0%0.00%0.0%
Q4 2018$7,000
-41.7%
2500.0%0.00%0.0%
Q3 2018$12,000
-64.7%
250
-68.4%
0.00%
-66.7%
Q2 2018$34,000
+17.2%
790
-20.2%
0.00%
+50.0%
Q1 2018$29,000
-14.7%
9900.0%0.00%
-33.3%
Q4 2017$34,000
-5.6%
9900.0%0.00%
-25.0%
Q3 2017$36,000
-7.7%
990
-33.6%
0.00%
-20.0%
Q2 2017$39,000
+21.9%
1,490
-11.8%
0.01%0.0%
Q1 2017$32,000
-84.6%
1,690
-83.3%
0.01%
-87.2%
Q3 2016$208,000
-65.3%
10,115
-48.4%
0.04%
-71.3%
Q2 2016$600,000
-11.9%
19,600
+7.7%
0.14%
-26.9%
Q1 2016$681,000
-6.1%
18,205
+8.4%
0.19%
-20.2%
Q4 2015$725,000
+20.8%
16,789
+4.8%
0.23%
+28.7%
Q3 2015$600,000
+27.9%
16,015
+17.4%
0.18%
+31.2%
Q2 2015$469,000
+8.3%
13,645
+10.5%
0.14%
+15.0%
Q1 2015$433,000
+1.6%
12,345
+10.0%
0.12%
-9.8%
Q4 2014$426,000
+27.9%
11,220
+29.8%
0.13%
+9.0%
Q3 2014$333,0008,6450.12%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders